Rapport Therapeutics’ $150 Million Series B Funding Round

Pietro Martinoia North America Legal Chronicle
Tagged:

Goodwin advised Rapport Therapeutics on the fundraising.Rapport Therapeutics announced the completion of its $150 million in Series B funding. Led by Cormorant Asset Management, the round…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Pietro Martinoia

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here